Available Until 9/25/2026
View Cart

Anticoagulant Reversal

ACPE Activity Number: 0204-0000-24-095-H01-P 
Release Date: September 25, 2024
Expiration Date: September 25, 2026
Activity Type: Knowledge-based
CE Credits:  0.25 contact hourS, no partial credit
Activity Fee: Member – Free / Non-Member – Not Available 

Activity Overview 

Anticoagulants are commonly used in the United States for various indications. One major adverse effect associated with anticoagulant use is bleeding. Patients experiencing major or minor bleeding may qualify for anticoagulant reversal due to bleeding. This presentation will highlight anticoagulant reversals and how to choose the best option when presented with a patient case. 

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience

These activities were planned to meet the educational needs of individuals working in acute care settings who encounter patients experiencing acute opioid withdrawal as well as those in the outpatient setting in addictions clinics assisting with long-term recovery.

Learning Objectives

After participating in this CPE activity, participants should be able to:

  • Describe the pharmacology of anticoagulation reversal agents.
  • Discuss the indications for appropriate anticoagulation reversal.
  • Identify appropriate anticoagulation reversal agent based on a reversal algorithm and patient case. 

  • Introduction and Announcements 

  • Presentation  

Faculty

Marianne Pop, PharmD, MPH, BCPS
University of Illinois Chicago
College of Pharmacy
Rockford, IL 61107 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.